Cancerlife is a digital health startup founded in 2013 that has developed an app specifically aimed at improving the quality of life for cancer patients, survivors, and caregivers. The app serves as a messaging platform that allows survivors to update their health status to family and friends through various social networks and messaging platforms such as Facebook, Whatsapp, email, text, and Messenger.
The app also collects critical patient-reported outcomes data automatically and presents it in reports that survivors can share with their doctors. Currently, Cancerlife's platform is undergoing a clinical trial to prove its efficacy in enhancing the overall quality of life for cancer patients. The company aspires to be the first digital therapeutic in cancer care, making its efforts innovative and potentially impactful within the healthcare industry.
As of the latest available information, the company has not publicly disclosed its headquarters or the details of its last investment and associated investors. However, with its focus on leveraging big data and digital health technologies within the realm of healthcare, Cancerlife presents an intriguing prospect for potential investment and signifies a promising development in the intersection of technology and healthcare.